Want to see IN:MAXHEALTH full AI Analyst Report?
MAXHEALTH Stock Chart & Stats
₹1202.35
₹4.85(0.40%)
At close: 4:00 PM EST
₹1202.35
₹4.85(0.40%)
Day’s Range― - ―
52-Week Range₹903.50 - ₹1,314.30
Previous CloseN/A
Volume2.66M
Average Volume (3M)80.22K
Market Cap
₹1.09T
Enterprise Value₹1.03T
Total Cash (Recent Filing)₹5.73B
Total Debt (Recent Filing)₹32.75B
Price to Earnings (P/E)77.5
Beta1.14
Next Earnings
Aug 11, 2026EPS Estimate
4.21Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)13.96
Shares Outstanding973,243,800
10 Day Avg. Volume58,776
30 Day Avg. Volume80,220
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)8.67
Price to Sales (P/S)11.13
P/FCF Ratio626.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)19.91
Revenue Forecast (FY)₹120.24B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained multi-year revenue expansion indicates durable demand for hospital services and successful scaling of capacity and specialties. A growing top line supports reinvestment in facilities and talent, and reduces per-unit overhead, strengthening long-term competitive position and market share.
Operating Profitability & MarginsImproved gross margins and sustained operating profitability suggest structural cost control and pricing power in higher-acuity services. Durable operating margins underpin the ability to fund capex and expansion, and provide resilience through cycles versus lower-margin competitors.
Balance Sheet Quality & ROE RecoveryA sizable equity base and recovering ROE provide long-term financial flexibility and buffer against shocks. Improving returns indicate that capital deployment is becoming more efficient, supporting sustained investment in facilities and talent without immediate reliance on external financing.
Bears Say
Recent Sharp Debt IncreaseA step-up in leverage elevates interest expense sensitivity and constrains strategic optionality. Higher debt increases refinancing and liquidity risk if rates rise or cash generation weakens, potentially limiting ability to pursue expansions or absorb operational shocks over the next several quarters.
Volatile And Deteriorating Free Cash FlowWeak and inconsistent free cash flow undermines funding for capex, deleveraging, and shareholder returns. Poor cash conversion (OCF covering ~80% of net income; FCF ~34% of net income in 2025) signals that reported profits may not reliably translate into cash for investment or debt service.
Margin Compression / Lower Operating Profit In 2026A downtrend in net margins and declining operating profit indicate structural pressure from costs, mix shifts, or pricing limits. If sustained, margin erosion could reduce internal funding capacity and make long-term growth investments or debt repayment more challenging.
MAXHEALTH FAQ
What was Max Healthcare Institute Ltd’s price range in the past 12 months?
Max Healthcare Institute Ltd lowest stock price was ₹903.50 and its highest was ₹1314.30 in the past 12 months.
What is Max Healthcare Institute Ltd’s market cap?
Max Healthcare Institute Ltd’s market cap is ₹1.09T.
When is Max Healthcare Institute Ltd’s upcoming earnings report date?
Max Healthcare Institute Ltd’s upcoming earnings report date is Aug 11, 2026 which is in 42 days.
How were Max Healthcare Institute Ltd’s earnings last quarter?
Max Healthcare Institute Ltd released its earnings results on May 21, 2026. The company reported ₹3.5 earnings per share for the quarter, missing the consensus estimate of ₹4.155 by -₹0.655.
Is Max Healthcare Institute Ltd overvalued?
According to Wall Street analysts Max Healthcare Institute Ltd’s price is currently Overvalued.
Does Max Healthcare Institute Ltd pay dividends?
Max Healthcare Institute Ltd pays a Annually dividend of ₹1.998 which represents an annual dividend yield of 0.14%. See more information on Max Healthcare Institute Ltd dividends here
What is Max Healthcare Institute Ltd’s EPS estimate?
Max Healthcare Institute Ltd’s EPS estimate is 4.21.
How many shares outstanding does Max Healthcare Institute Ltd have?
Max Healthcare Institute Ltd has 973,243,800 shares outstanding.
What happened to Max Healthcare Institute Ltd’s price movement after its last earnings report?
Max Healthcare Institute Ltd reported an EPS of ₹3.5 in its last earnings report, missing expectations of ₹4.155. Following the earnings report the stock price went up 1.417%.
Which hedge fund is a major shareholder of Max Healthcare Institute Ltd?
Currently, no hedge funds are holding shares in IN:MAXHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Max Healthcare Institute Ltd
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―








